Biogen, Ionis terminates development of ALS investigational drug EP News Bureau May 17, 2024 Topline results from the Phase 1/2 ALSpire study indicated no reduction in levels of plasma neurofilament light chain (NfL), a…
AstraZeneca and Ionis eye US approval after positive trial data Reuters Jun 22, 2022 Based on the results, the companies plan to file an application to market the therapy in the US later this year in patients with…
